Pharmacokinetics Flashcards

1
Q

Pharmacokinetics

A

how drugs enter & leave the body; plasma drug concentrations vs time; what the body does to a drug, and how to avoid complications. Aka ADME

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

ADME

A

Absorption from site of administration, Distribution within the body, Metabolism, Excretion

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

Systemic drug administration

A

Given into blood. Needs to act at inaccessible site.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

Local drug administration

A

Given direct to site of action. E.g. local anaesthetic

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

Oral administration

A

<100%. Depends on solubility; drug pKa, pH of GI tract; stability (acid may destroy); gastric emptying and GI motility (mostly absorbed in upper GI; emptying slowed by food; motility depends on drugs and disease); GI blood flow; First pass effect (can get lost in hepatic portal vein before reaching systemic circulation)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

First pass effect

A

Most of GI tract goes through hepatic portal vein to liver, so drug can be metabolized before reaching systemic circulation.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

Bioavailability

A

% of dose reaching systemic circulation. Loss loss due to metabolism or excretion; direct effect on therapeutic outcome; different for different formulations; may vary with liver function

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

Advantage of oral route

A

No need for drug to be pure or sterile; easy for patient, no pain - most common; cheap formulations, multi-dose bottles

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

Disadvantage of oral route

A

Requires conscious, cooperative patient; slow, so no good for emergencies; variable absorption and bioavailability; loss of drug if patient vomits; potential for upper GI tract irritation (less damage if accompanied with food)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

Rectal administration

A

Obvious! fairly rapid absorption possible; less first-pass effect.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

Pros and cons of rectal

A

Good for patients who cannot swallow (unconscious); won’t swallow (children, psychotics); may be vomiting. Mildly inconvenient.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

Parenteral route

A

Means not via enteral route (ie not between glottis and anus), but not only injection

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

Sulbligual

A

direct entry to systemic circ. (no first pass); rapid absorption possible despite low area; pH about 7 so acid-labile drugs are stable; fast, easy, comfortable

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

IV

A

Can be rapid (IV push) or slow (IV drip or infusion) - concentration can increase quickly or gradually; acts quickly. Need skill to find veins; drug cannot cause pain or damage; need sterile solutions; greater risk and cost

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

Other routes of administration

A

subcutaneous, vaginal, intramuscular, intracardiac, urethral, transdermal, inhalation, topical, intranasal, intrathecal, spinal, buccal, intra-articular, occular

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

Drug distribution

A

Depends on solubility of drug in fat or tissue; pH of compartment and pKa of drug (effect of charge); plasma protein binding. this can affect the duration of action or how long the drug stays in body. Needs to be unbound and free for diffusion across membranes; binding to receptors and enzymes; hepatic metabolism and renal filtration

17
Q

Termination of drug effects

A

Biotransformation aka metabolism. Body wants to make it more polar Phase I: drug made more polar by cytochrome P450 enzyme families (CYPs) - change to drug; Phase II: drug conjugation to endogenous compounds from liver, so the addition makes it more polar

18
Q

Where does drug metabolism occur?

A

most occurs in the liver; may also occur in kidneys, gut, lungs, plasma and placenta; polar products undergo renal elimination

19
Q

Drug metabolites

A

may be many for a single drug; usually most are inactive; rarely have biological activity; more rarely, an inactive drug (called a “pro-drug”) may be activated by metabolism

20
Q

What can affect metabolic rate?

A

Can be increased or decreased by age, disease, genetics, diet, tobacco, alcohol, other meds

21
Q

How are drugs excreted?

A

Kidney: can be affected by kidney disease, renal blood flow, MW urinary pH, protein binding. Gall bladder: may get secreted from liver into bile; some drug reabsorption from bile in gut; termed enterohepatic circulation

22
Q

First order elimination

A

constant proportion lost per unit time. Proportional to the concentration. Straight line on a log graph. Easy calculations for initial conc. and t1/2. Drug is accepted as “gone” after 4 or 5 t1/2

23
Q

Zero order elimination

A

Less common. Constant amount lost per unit time. Straight line on a normal linear graph, nosedive on log scale. Often after enzymes are saturated. Classic example is ethanol.

24
Q

What effect does doubling the dose have for a first order drug?

A

It does NOT double the duration. It increases duration by one half the time, or by 50%. (think of it, half-life)

25
Q

Volume of distribution, Vd

A

Volume in which drug “seems” to be dissolved. If 10 mg is given via IV, and [plasma] .25mg/L, the Vd is 40L. Larger Vd indicates lots of drug binding so very little free in plasma. Vd affected by gender, age, disease. [plasma] = drug dose/Vd

26
Q

Drug clearance, CL

A

volume/unit time. volume refers to volume of plasma cleared of drug. CL is additive, so renal + hepatic + other

27
Q

Compartment models

A

Single: consider body as one box that it goes in and out of. 2 compartment: 2 boxes. Into one then into a second one or cleared directly from first; two phases of elimination: a is quick initially, then ß is slower

28
Q

Multiple drug dosing

A

Need to maintain therapeutic conc. Either increase dose (toxic?) or reduce dosing interval so you reach an equilibrium usually in 4-5 t1/2

29
Q

Loading dose

A

Decreases time to plateau. Best is loading dose plus continuous infusion. Reaches plateau fast and stays there